🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| Sodium-dependent noradrenaline transporter (SLC6A2) | Inhibitor | 8.69 Kd | DRUGCENTRAL | TargetSodium-dependent noradrenaline transporter (SLC6A2) ActionInhibitor Affinity8.69 Kd SourceDRUGCENTRAL |
| Cytochrome P450 2D6 (CYP2D6) | — | 4.77 Ki | DRUGCENTRAL | TargetCytochrome P450 2D6 (CYP2D6) Action— Affinity4.77 Ki SourceDRUGCENTRAL |
| G protein-activated inward rectifier potassium channel 2 (KCNJ6) | — | 4.282 IC50 | DRUGCENTRAL | TargetG protein-activated inward rectifier potassium channel 2 (KCNJ6) Action— Affinity4.282 IC50 SourceDRUGCENTRAL |
| Kir3.1/Kir3.2 (KCNJ6) | — | 4.478 IC50 | DRUGCENTRAL | TargetKir3.1/Kir3.2 (KCNJ6) Action— Affinity4.478 IC50 SourceDRUGCENTRAL |
| Kir3.1/Kir3.4 (KCNJ5) | — | 4.845 IC50 | DRUGCENTRAL | TargetKir3.1/Kir3.4 (KCNJ5) Action— Affinity4.845 IC50 SourceDRUGCENTRAL |
| Krueppel-like factor 10 (KLF10) | — | 4 IC50 | DRUGCENTRAL | TargetKrueppel-like factor 10 (KLF10) Action— Affinity4 IC50 SourceDRUGCENTRAL |
| Potassium voltage-gated channel subfamily H member 2 (KCNH2) | — | 5.68 IC50 | DRUGCENTRAL | TargetPotassium voltage-gated channel subfamily H member 2 (KCNH2) Action— Affinity5.68 IC50 SourceDRUGCENTRAL |
| Sodium-dependent dopamine transporter (SLC6A3) | — | 5.97 Kd | DRUGCENTRAL | TargetSodium-dependent dopamine transporter (SLC6A3) Action— Affinity5.97 Kd SourceDRUGCENTRAL |
| Sodium-dependent serotonin transporter (SLC6A4) | — | 8.05 Kd | DRUGCENTRAL | TargetSodium-dependent serotonin transporter (SLC6A4) Action— Affinity8.05 Kd SourceDRUGCENTRAL |
| Transporter (Slc6a2) | — | 9.15 Ki | DRUGCENTRAL | TargetTransporter (Slc6a2) Action— Affinity9.15 Ki SourceDRUGCENTRAL |
External links
PubChem 54841 ↗CAS 83015-26-3 ↗ChEBI CHEBI:127342 ↗ChEMBL CHEMBL641 ↗KEGG D07473 ↗DrugBank DB00289 ↗ChemSpider ↗ChEBI/ChEMBL ↗Guide to Pharmacology ↗NIH ↗NIH ↗DrugBank ↗ChEBI/ChEMBL ↗NIH ↗NIH ↗NIH ↗CAS 1027094-45-6 ↗CAS 63940-51-2 ↗CAS 82248-59-7 ↗PsychonautWiki ↗Erowid ↗Experience reports (PiHKAL) ↗Experience reports (TiHKAL) ↗
Source: DrugCentral — Atomoxetine ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.